Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

BACKGROUND: The clinical benefit of galcanezumab, demonstrated in randomized clinical trials (RCTs), remains to be quantified in real life. This study aimed at evaluating the effectiveness, safety and tolerability of galcanezumab in the prevention of high-frequency episodic migraine (HFEM) and chron...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Headache Pain
Main Authors: Vernieri, Fabrizio, Altamura, Claudia, Brunelli, Nicoletta, Costa, Carmelina Maria, Aurilia, Cinzia, Egeo, Gabriella, Fofi, Luisa, Favoni, Valentina, Pierangeli, Giulia, Lovati, Carlo, Aguggia, Marco, d’Onofrio, Florindo, Doretti, Alberto, Di Fiore, Paola, Finocchi, Cinzia, Rao, Renata, Bono, Francesco, Ranieri, Angelo, Albanese, Maria, Cevoli, Sabina, Barbanti, Piero
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Milan 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8091153/
https://ncbi.nlm.nih.gov/pubmed/33941080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-021-01247-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados